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Abstract 
Review on t(2;2)(p22;p22) and del(2)(p22p22) 
LTBP1/BIRC6 in acute myeloid leukemia, with 
data on the genes involved. 
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Clinics and pathology 
Only two cases to date of t(2;2)(p22;p22) or 
del(2)(p22p22) LTBP1/BIRC6 in acute myeloid 
leukemia have been described (Cancer Genome 
Atlas Research Network 2013; Yoshihara et al. 
2015). This chromosomes and genes 
rearrangements have also been found in a case of 
breast carcinoma, and in a case of lung squamous 
cell carcinoma. 
Disease 
Acute myeloid leukemia 
Epidemiology 
Data were described in only one case: a 75-year old 
male patient presented with AML-M2. Overall 
survival was 0.1 month (Cancer Genome Atlas 
Research Network 2013). 
Cytogenetics 
The karyotype was normal (cryptic rearrangement). 
Genes involved and 
proteins 
FLT3 mutation was positive; IDH1 R132, R140, 
R172 were negative; activating RAS was negative; 
NPMc was negative. 
BIRC6 (Baculoviral IAP repeat-
containing 6) 
Location 2p22.3 
Protein 
BIRC6 contains two domains: a N-terminal BIR 
repeat (needed for interactions with caspases and 
IAP-binding motif (IBM) containing proteins) and a 
C-terminal UBC domain (which can form a 
thiolester linkage with ubiquitin transferred by E1). 
Inhibitor of apoptosis: BIRC6 is a peripheral 
membrane protein of the trans-Golgi network that 
protects cells from apoptosis  
BIRC6 and treatment resistance: Silencing of 
BIRC6 has been shown to sensitize cancer cells to 
various anticancer agents 
BIRC6 is essential in embryonic development.  
Regulator of cytokinesis: BIRC6 is a major 
regulator of abscission, the final stage of 
cytokinesis.  
Regulator of mitosis: BIRC6 interacts with CCNA2 
(cyclin A) and promotes its degradation in early 
mitosis  
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BIRC6 and autophagy: BIRC6 is required to inhibit 
autophagy (Iris Luk and Wang, 2014).  
BIRC6 is involved in myelodysplastic syndromes 
and acute myeloid leukemias, colorectal cancer, 
neuroblastoma, skin melanoma, non-small cell lung 
cancer, prostate cancer, ovarian cancer, 
hepatocellular carcinoma and breast cancer. 
LTBP1 (latent transforming growth 
factor beta binding protein 1) 
Location 2p22.3 
DNA/RNA 
Eleven splice variants. 
Protein 
1721 amino acids; belongs to the LTBP/fibrillin 
family.  
LTBP1 is composed of a signal peptide: (amino 
acids 1-23), 18 epidermal growth factor (EGF)-like 
repeats and four cysteines rich domains, the TB 
(TGFb binding protein-like) domains.  
The LTBP1 C-terminus interacts with the 
extracellular matrix via fibrillin microfibrils. EGF-
like repeats provide stability to the protein structure  
TGFB1 is secreted as a biologically latent complex 
composed of LTBP1, a latency associated peptide 
(LAP), (LAP is the TGFB1 pro-peptide which 
regulates latency, that is cleaved intracellularly 
prior to secretion), and the TGFB1 cytokine. 
LTBP1 plays roles in facilitating the folding and 
secretion of TGFB1 from the cell, and activation.  
LTBP1 interacts with FBN1 (fibrillin 1).  
This interaction allows LTBP1 to sequester TGFB1 
to fibrillin microfibrils; EFEMP2 (EGF containing 
fibulin-like extracellular matrix protein 2, or 
fibulin4) and ADAMTSL proteins form ternary 
complexes with LTBP1 and fibrillin.  
LTBP1 is involved in epithelial-mesenchymal 
interaction and epithelial differentiation (Mazzieri 
et al., 2005; Robertson et al., 2014). 
Result of the chromosomal 
anomaly 
Hybrid gene 
Description 
5' LTBP1 - 3' BIRC6 
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